{"drugs":["Betaine","Cystadane"],"mono":{"0":{"id":"924089-s-0","title":"Generic Names","mono":"Betaine"},"1":{"id":"924089-s-1","title":"Dosing and Indications","sub":{"0":{"id":"924089-s-1-4","title":"Adult Dosing","mono":"<b>Homocystinuria:<\/b> 3 grams ORALLY twice daily, doses may be gradually increased until plasma homocysteine exists in small amounts or is undetectable "},"1":{"id":"924089-s-1-5","title":"Pediatric Dosing","mono":"<ul><li><b>Homocystinuria:<\/b> (less than 3 y of age) 100 mg\/kg\/day, increase dose weekly by 100 mg\/kg until plasma homocysteine exists in small amounts or is undetectable<\/li><li><b>Homocystinuria:<\/b> (3 y and older) 3 grams ORALLY twice daily, doses may be gradually increased until plasma homocysteine exists in small amounts or is undetectable<\/li><\/ul>"},"3":{"id":"924089-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Homocystinuria<br\/><b>Non-FDA Labeled Indications<\/b><br\/>Non-alcoholic fatty liver<br\/>"}}},"3":{"id":"924089-s-3","title":"Contraindications\/Warnings","sub":[{"id":"924089-s-3-9","title":"Contraindications","mono":"Hypersensitivity to betaine<br\/>"},{"id":"924089-s-3-10","title":"Precautions","mono":"Unknown<br\/>"},{"id":"924089-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"924089-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"924089-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Gastrointestinal:<\/b>Diarrhea, Drug-induced gastrointestinal disturbance, Nausea<br\/>"},"6":{"id":"924089-s-6","title":"Drug Name Info","sub":{"0":{"id":"924089-s-6-17","title":"US Trade Names","mono":"Cystadane<br\/>"},"2":{"id":"924089-s-6-19","title":"Class","mono":"Digestant<br\/>"},"3":{"id":"924089-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"924089-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"924089-s-7","title":"Mechanism Of Action","mono":"<ul><li>Systemic: Betaine acts as a methyl group donor in the remethylation of homocysteine to methionine in patients with homocystinuria. This reduces toxic concentrations of homocysteine, usually to 20 to 30% or less of pretreatment concentrations .<\/li><li>Betaine also has been shown to increase low plasma methionine and S-adenosylmethionine concentrations in patients with 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency and cobalamin cofactor metabolism (cbl) defect .<\/li><\/ul>"},"9":{"id":"924089-s-9","title":"Administration","mono":"<b>Oral<\/b><br\/><ul><li>(powder for solution) may be administered concomitantly with vitamin B6, vitamin B12 and folate<\/li><li>(powder for solution) measure with scoop provided; 1 level scoop (1.7 cc) = 1 gram betaine anhydrous powder<\/li><li>(powder for solution) dissolve in 4-6 ounces water, juice, milk, formula, or mix with food for immediate ingestion<\/li><\/ul>"},"10":{"id":"924089-s-10","title":"Monitoring","mono":"<ul><li>plasma homocysteine level<\/li><li>plasma methionine concentrations; in patients with cystathionine beta-synthase deficiency<\/li><\/ul>"},"11":{"id":"924089-s-11","title":"How Supplied","mono":"<b>Cystadane<\/b><br\/>Oral Powder for Suspension: 1 GM\/Scoopful<br\/>"},"13":{"id":"924089-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause diarrhea or nausea.<\/li><li>May be taken concomitantly with vitamin B6, vitamin B12, and folic acid.<\/li><\/ul>"}}}